MarketPeel
Pricing
…
President and CEO
Peter Blume-jensen
Sat, Mar 1, 2025
Mar 1
received an award in ACRV
390,390 shares @ $0.00
New position
ACRVAcrivon Therapeutics, Inc.
Health CarePharmaceuticals
1D-0.91%
1W+6.34%
1M+36.25%
3M+31.33%
6M—
1Y—

Recent insider activity at ACRV

Aug 18Katharine PetersonSold$203.01Aug 18Eric DevroeSold$1.21kAug 18Erick GamelinSold$804.00Aug 18Mary MillerSold$371.85Aug 18Peter Blume-jensenSold$972.84Aug 18Peter Blume-jensenSold$2.47kAug 4Adam D. LevySold$1.79kJul 21Mary MillerSold$1.01k
Full ACRV profile →Peter Blume-jensen’s trading history →
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback